LLY · 8-K · 20260430PR000043
Product Revenue - Mounjaro
ELI LILLY & Co · 2026-04-30 · Importance 89 · Surprise 82 · No source text
Worldwide Mounjaro revenue in Q1 2026 increased 125% to $8.7 billion versus Q1 2025. U.S. Mounjaro revenue was $4.2 billion in Q1 2026, up 59% year-over-year, driven by strong demand but partially offset by lower realized prices. Outside the U.S., Mounjaro revenue increased to $4.4 billion from $1.2 billion in Q1 2025, primarily driven by volume growth and partially offset by lower realized prices due to inclusion on China's NRDL. Q1 2026 included a favorable one-time adjustment to rebate and discount estimates that partially offset lower realized prices in the U.S.
Key facts
- Mounjaro Q1 2026 revenue increased 125% to $8,662 million worldwide source
- Mounjaro revenue outside the U.S. was $4.4 billion in Q1 2026 compared with $1.2 billion in Q1 2025 source
- Mounjaro U.S. revenue was $4.2 billion in Q1 2026, an increase of 59% source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +24.3% | Mounjaro Q1 2026 revenue increased 125% to $8,662 million worldwide |